Frank J. Williams Sells 20,000 Shares of Evolent Health, Inc. (NYSE:EVH) Stock

Evolent Health, Inc. (NYSE:EVH) Chairman Frank J. Williams sold 20,000 shares of Evolent Health stock in a transaction dated Friday, September 17th. The stock was sold at an average price of $26.27, for a total value of $525,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Frank J. Williams also recently made the following trade(s):

  • On Friday, July 30th, Frank J. Williams sold 3,502 shares of Evolent Health stock. The stock was sold at an average price of $23.00, for a total value of $80,546.00.

Shares of EVH traded down $0.78 during mid-day trading on Monday, reaching $25.67. 550,194 shares of the company’s stock traded hands, compared to its average volume of 536,731. Evolent Health, Inc. has a 12 month low of $9.44 and a 12 month high of $26.86. The stock has a market capitalization of $2.24 billion, a P/E ratio of -31.49 and a beta of 2.40. The business’s 50-day moving average price is $23.80 and its 200-day moving average price is $21.43. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.25 and a current ratio of 1.25.

Evolent Health (NYSE:EVH) last announced its earnings results on Wednesday, August 4th. The technology company reported ($0.06) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.11) by $0.05. Evolent Health had a negative return on equity of 3.38% and a negative net margin of 7.28%. The firm had revenue of $222.06 million for the quarter, compared to analysts’ expectations of $216.97 million. Equities research analysts anticipate that Evolent Health, Inc. will post -0.27 EPS for the current year.

A number of brokerages have commented on EVH. Zacks Investment Research downgraded Evolent Health from a “buy” rating to a “hold” rating in a research note on Wednesday, August 11th. Piper Sandler lifted their target price on Evolent Health from $29.00 to $30.00 and gave the company an “overweight” rating in a research note on Thursday, August 5th. Canaccord Genuity lifted their target price on Evolent Health from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Thursday, August 5th. TheStreet upgraded Evolent Health from a “d” rating to a “c-” rating in a research note on Monday, August 23rd. Finally, BTIG Research lifted their target price on Evolent Health from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Monday, September 13th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $28.40.

A number of large investors have recently made changes to their positions in the stock. Parametric Portfolio Associates LLC raised its holdings in Evolent Health by 3.5% during the second quarter. Parametric Portfolio Associates LLC now owns 88,733 shares of the technology company’s stock worth $1,874,000 after purchasing an additional 2,998 shares in the last quarter. Redwood Investment Management LLC raised its holdings in Evolent Health by 31.6% during the second quarter. Redwood Investment Management LLC now owns 85,308 shares of the technology company’s stock worth $1,802,000 after purchasing an additional 20,495 shares in the last quarter. Metropolitan Life Insurance Co NY raised its holdings in Evolent Health by 106,490.5% during the second quarter. Metropolitan Life Insurance Co NY now owns 22,384 shares of the technology company’s stock worth $473,000 after purchasing an additional 22,363 shares in the last quarter. Millennium Management LLC raised its holdings in Evolent Health by 213.0% during the second quarter. Millennium Management LLC now owns 264,533 shares of the technology company’s stock worth $5,587,000 after purchasing an additional 180,024 shares in the last quarter. Finally, Squarepoint Ops LLC increased its holdings in shares of Evolent Health by 85.5% in the second quarter. Squarepoint Ops LLC now owns 49,656 shares of the technology company’s stock valued at $1,049,000 after buying an additional 22,890 shares in the last quarter. 94.50% of the stock is currently owned by hedge funds and other institutional investors.

About Evolent Health

Evolent Health, Inc engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration.

Further Reading: How do investors use RSI to grade stocks?

Insider Buying and Selling by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.